Radiopharmaceuticals for cancer treatment
Discover new opportunities for your molecules in radiopharma
26.4 million new cancer cases and 17 million deaths every year worldwide – those are the estimates for 2030. The quest for improved cancer treatments has become more urgent than ever. And with the unexplored potential of your molecules to be used as a radiopharmaceutical at your fingertips, you could be well on your way to discover new medical opportunities and more effective cancer treatments.
SCK CEN is a pre-clinical research partner and manufacturer of medical radioisotopes specialising in the field of radiopharmaceuticals. Engage our unique expertise, infrastructure, and focus to help you discover new opportunities in the fight against cancer.
SCK CEN accelerates the fight against cancer
Our cancer research program is constantly developing new knowledge in various fields of nuclear medicine. With all of our combined expertise, we can optimally contribute to your research and development of next-generation radiopharmaceuticals for treating cancer.
Two SCK CEN assets for you
We have two strong assets to help bring radiopharmaceuticals to maturity:
1. Comprehensive, multidisciplinary knowledge to drive research & development forward
SCK CEN takes its responsibility as a research centre seriously. That means we perform new fundamental radiopharmaceutical research – with a clear focus on interdisciplinary knowledge creation.
If you work at a university, pharma or bio-tech company and need to understand the fundamental radiopharmaceutical mechanisms, our radiochemistry, radiobiology, radiopharmacy and dosimetry scientists are there to support you.
EExxpplloorree rraaddiioopphhaarrmmaacceeuuttiiccaall RR&&DD ooppppoorrttuunniittiieess
2. Direct access to radioisotopes
Our BR2 research reactor has long been an essential link in the production of medical radioisotopes. In addition, our brand-new production facility, the CRF where we can use radiochemical techniques to isolate promising, therapeutic radioisotopes, is under construction. The whole process follows GMP guidelines.
We have the unique infrastructure and licences to produce a large number of radioisotopes. Why not yours too?
FFiinndd oouutt hhooww wwee ddoo tthhiiss ffoorr 117777--LLuutteettiiuumm
How SCK CEN can help you in the fight against cancer
-
Explore the world of radiopharmaceutical applications without missing crucial opportunities. Thanks to our unique radiopharmaceutical expertise, infrastructure, and focus, SCK CEN helps you prove the potential of your research in no time.
-
Radiopharmaceutical research opens a world of new opportunities for your molecules, and with validated potential you open a new source of investment. We provide you with the results you need for your board meeting or investment pitch.
-
Are you getting the most out of your research? Or your molecule? Radiopharmaceuticals can have a huge impact on the fight against cancer if you have the right knowledge. Explore new opportunities, secure funding and make the right decisions.